Cipla Limited has officially announced the launch of Yurpeak® (tirzepatide), marking a landmark entry into the high-growth...
Year: 2025
Glenmark Pharmaceuticals Inc., USA, has announced the official launch of Leucovorin Calcium for Injection USP (350 mg/vial)....
The U.S. Food and Drug Administration (FDA) has officially approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), a milestone...
Merck (known as MSD outside the U.S. and Canada) has announced transformative topline results from the Phase...
Researchers from the Walter and Eliza Hall Institute (WEHI) and global biopharmaceutical leader MSD (Merck & Co.,...
The Government of India has announced an ambitious roadmap to expand the reach of affordable healthcare under...
India’s journey toward “Aatmanirbharta” (self-reliance) in the healthcare sector has reached a major milestone. Under the federal...
In a landmark move for the Indian pharmaceutical sector, Pfizer India and Cipla Limited have officially entered...
Merck (known as MSD outside the U.S. and Canada) and Cidara Therapeutics, Inc., a biotechnology company specializing...
Novartis, in partnership with Medicines for Malaria Venture (MMV), has announced compelling Phase III results for their...
